Leaders in infection and global health

Advancing knowledge. Improving outcomes.

With its international standing and long tradition in infectious disease and tropical medicine, the University of Liverpool is the natural home for a research institute dedicated to infection and global health. Read more about our mission.

We have 110 full-time academic staff, including 24 professors, as well as 53 professional services staff and 170 research students, all working to further the diagnosis, treatment and prevention of today's prevalent and emerging infectious diseases.

In developing this Strategic Plan, we have examined our strengths, and identified the global challenges that our work seeks to address. These challenges – relating to the growing needs to predict, diagnose, treat and prevent infectious diseases in animals and humans – are both real and big: they threaten the livelihood and welfare of people globally, as they affect the security and safety of our food supply or contribute to the spread of preventable or curable illnesses.

We work across 5 major research challenges (as identified in our IGH Strategic plan 2016 - 2021), organised through three departments:-

‌Much of our research is interdisciplinary and we work with a vast range of experts and partners, internationally and within the University itself. Crucially, our programmes have saved thousands, possibly millions of lives.

We've strong funding to continue our work. Research income stands at £13.5m per year, from partners including the UK research councils, Wellcome Trust, NIHR, Gates Foundation, Leverhulme Trust, Pfizer, European Commission and Novartis.

This, together with strong backing from the University, is enabling us to expand steadily.

Join with us. Our pioneering work has just begun.

Further links:

Our departments:

Our major research Challenges: